- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,457,135
- Total 13F shares
- 9,137,601
- Share change
- +2,300,377
- Total reported value
- $454,036,000
- Price per share
- $49.69
- Number of holders
- 43
- Value change
- +$118,577,913
- Number of buys
- 31
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M96088105:
Top shareholders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
3.1%
|
1,510,007
|
$56,187,000 | — | 31 Dec 2017 | |
| Consonance Capital Management LP |
13F
|
Company |
1.9%
|
916,450
|
$34,101,000 | — | 31 Dec 2017 | |
| FMR LLC |
13F
|
Company |
1.4%
|
689,830
|
$25,669,000 | — | 31 Dec 2017 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
519,090
|
$19,315,000 | — | 31 Dec 2017 | |
| MEITAV INVESTMENT HOUSE LTD |
13F
|
Company |
0.85%
|
412,882
|
$15,363,000 | — | 31 Dec 2017 | |
| HIGHLINE CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.83%
|
399,900
|
$14,880,000 | — | 31 Dec 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.46%
|
224,000
|
$8,335,000 | — | 31 Dec 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.41%
|
199,014
|
$7,405,000 | — | 31 Dec 2017 | |
| DSAM Partners (London) Ltd |
13F
|
Company |
0.28%
|
136,500
|
$5,079,000 | — | 31 Dec 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.27%
|
131,100
|
$4,878,000 | — | 31 Dec 2017 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
0.26%
|
127,313
|
$4,738,000 | — | 31 Dec 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.15%
|
70,700
|
$2,630,000 | — | 31 Dec 2017 | |
| Lyon Street Capital, LLC |
13F
|
Company |
0.12%
|
56,617
|
$2,107,000 | — | 31 Dec 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
50,667
|
$1,885,000 | — | 31 Dec 2017 | |
| Laurion Capital Management LP |
13F
|
Company |
0.1%
|
47,473
|
$1,766,000 | — | 31 Dec 2017 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.08%
|
38,461
|
$1,486,000 | — | 31 Dec 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
33,412
|
$1,243,000 | — | 31 Dec 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
23,740
|
$884,000 | — | 31 Dec 2017 | |
| SHIKIAR ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
21,025
|
$782,000 | — | 31 Dec 2017 | |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
|
Company |
0.04%
|
18,816
|
$700,000 | — | 31 Dec 2017 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.03%
|
14,603
|
$543,000 | — | 31 Dec 2017 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
0.03%
|
12,250
|
$456,000 | — | 31 Dec 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
11,485
|
$427,000 | — | 31 Dec 2017 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
10,200
|
$380,000 | — | 31 Dec 2017 | |
| ARK Investment Management LLC |
13F
|
Company |
0.02%
|
9,284
|
$345,000 | — | 31 Dec 2017 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
7,436
|
$277,000 | — | 31 Dec 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
7,145
|
$265,000 | — | 31 Dec 2017 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0.01%
|
6,845
|
$264,000 | — | 31 Dec 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
6,300
|
$234,000 | — | 31 Dec 2017 | |
| MYDA Advisors LLC |
13F
|
Company |
0.01%
|
6,000
|
$223,000 | — | 31 Dec 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
4,960
|
$185,000 | — | 31 Dec 2017 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
0.01%
|
4,461
|
$166,000 | — | 31 Dec 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
3,750
|
$140,000 | — | 31 Dec 2017 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.01%
|
2,824
|
$105,000 | — | 31 Dec 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,746
|
$102,000 | — | 31 Dec 2017 | |
| NORGES BANK |
13F
|
Company |
0%
|
1,334
|
$50,000 | — | 31 Dec 2017 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0%
|
1,100
|
$41,000 | — | 31 Dec 2017 | |
| ProQuest Associates IV LLC |
13F
|
Company |
2.3%
|
1,096,024
|
$40,783 | — | 31 Dec 2017 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
800
|
$30,000 | — | 31 Dec 2017 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0%
|
380
|
$14,000 | — | 31 Dec 2017 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0%
|
300
|
$11,000 | — | 31 Dec 2017 |
Institutional Holders of UroGen Pharma Ltd. - Common Stock (URGN) as of Q1 2018
As of 31 Mar 2018,
UroGen Pharma Ltd. - Common Stock (URGN) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,137,601 shares.
The largest 10 holders included
MENORA MIVTACHIM HOLDINGS LTD., Consonance Capital Management LP, ProQuest Associates IV LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, MEITAV DASH INVESTMENTS LTD, EcoR1 Capital, LLC, HIGHLINE CAPITAL MANAGEMENT, L.P., CREDIT SUISSE AG/, and Clal Insurance Enterprises Holdings Ltd.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2018 vs Q4 2017 Across Filers
Q4 2017 holders
40
Q1 2018 holders
43
Holder diff
3
| Investor | Q4 2017 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q4 2017 Value $ | Q1 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.